|
Home : Unsafe Drugs : Avandia : News Articles : That $43 Million R&D Figure. In the Pipeline: That $43 Million R&D Figure. In the Pipeline:
Metformin, ezetimibe, rosiglitazone and pioglitazone: none of these had any detailed mechanisms worked out for them while the money was being spent to develop them. These are the sorts of things we do around here in between having meetings to decide what color the package should be, and right after we do that thing where we all jump around in ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




